The settlement ends two lawsuits that claimed that some of the products were “deceptively marketed, advertised, labeled, and sold as `Non-Drowsy,’” but actually contained dextromethorphan, which may ...

NEW YORK, July 22 (Reuters) - The maker of Robitussin settled a consumer lawsuit that claimed its "non-drowsy" cough and flu medicine causes drowsiness, agreeing to pay $4.5 million and remove the ...

A nationwide class-action lawsuit settlement could bring payments to consumers who purchased Robitussin cough medicine products that were falsely marketed as "non-drowsy." The $4.5 million agreement, ...

Consumers who bought a popular cough syrup could be eligible for money as part of a class action settlement. Robitussin maker Haleon has agreed to pay $4.5 million to resolve claims it advertised the ...

"Here, plaintiff has tied her lung infection to Haleon’s product. Plaintiff alleged that she used the Robitussin product over a defined period approximately six weeks before the product was recalled ...